Видео ютуба по тегу Ras(On) Inhibitor

Combined Inhibition of the Ras Pathway and Autophagy as a Treatment Approach for Pancreatic Cancer
Combined Inhibition of the Ras Pathway and Autophagy as a Treatment Approach for Pancreatic Cancer
ESMO highlights: KRAS G12C inhibitors
ESMO highlights: KRAS G12C inhibitors
RAS Oncoproteins Therapeutic Vulnerabilities
RAS Oncoproteins Therapeutic Vulnerabilities
Drs. Banerji and Pachter Talk About RAF/MEK Inhibitor in RAS Mutant Tumors
Drs. Banerji and Pachter Talk About RAF/MEK Inhibitor in RAS Mutant Tumors
Drugging the Undruggable Cancer Targets
Drugging the Undruggable Cancer Targets
Advances in the development of KRAS inhibitors
Advances in the development of KRAS inhibitors
Inhibition of MEK to Treat Cancer: Focus on Melanoma
Inhibition of MEK to Treat Cancer: Focus on Melanoma
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras
RAS & Cancer: A Mighty Mutation
RAS & Cancer: A Mighty Mutation
Menacing Mutations: Examining the Role of the RAS Oncogene in Cancer Development
Menacing Mutations: Examining the Role of the RAS Oncogene in Cancer Development
Targeting the Oncogenic State of RAS with Tri-Complex Inhibitors
Targeting the Oncogenic State of RAS with Tri-Complex Inhibitors
Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and Chemotherapy
Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and Chemotherapy
TESLA: TG01/QS-21 ± PD-1 inhibitor for MRD in RAS mutated pancreatic cancer
TESLA: TG01/QS-21 ± PD-1 inhibitor for MRD in RAS mutated pancreatic cancer
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
The potential of KRAS inhibitors for non-small-cell lung cancer
The potential of KRAS inhibitors for non-small-cell lung cancer
PRIME Trial: RAS Mutations Defined in Colorectal Cancer
PRIME Trial: RAS Mutations Defined in Colorectal Cancer
Concurrent Inhibition of The RAS Pathway and Autophagy As a Treatment Approach for Pancreatic Cancer
Concurrent Inhibition of The RAS Pathway and Autophagy As a Treatment Approach for Pancreatic Cancer
Evaluating the role of pan-RAF inhibitors in RAF and RAS mutant tumors
Evaluating the role of pan-RAF inhibitors in RAF and RAS mutant tumors